866-997-4948(US-Canada Toll Free)

Global Market Study on Crohns Disease: Anti-inflammatory Drugs Segment Anticipated to be the Most Lucrative Segment Through 2024

Published By :

Persistence Market Research

Published Date : Jan 2017

Category :

Diseases & Conditions

No. of Pages : 120 Pages

In its recently published report titled Crohns Disease Market: Global Industry Analysis and Forecast, 2016-2024, Persistence Market Research presents an outlook of the global Crohns disease market for the projected period of eight years. The primary objective of the report is to offer insights into developments in the global Crohns disease market that are affecting global businesses and enterprises. The report provides updates on market opportunities and insights to understand the growth and performance of the key segments of the global Crohns disease market. Through extensive research, Persistence Market Research analysts have studied how the different market dynamics are likely to impact the current and future scenario of the global Crohns disease market, thereby providing useful insights to market players to plan their future business strategies. The report covers the global Crohns disease market performance in terms of revenue contribution from various segments. This report also includes Persistence Market Researchs exclusive analysis of key trends, drivers, restraints and opportunities, which are influencing the growth of the global Crohns disease market. Impact analysis of key growth drivers and restraints are included in this report to better equip clients with crystal clear decision-making insights.

Report description

The report on the global Crohns disease market begins with an overview of Crohns disease, types of drugs used for treatment and key market definitions. The analysts also present an executive summary along with market taxonomy where the global Crohns disease market is segmented on the basis of drug type, distribution channel and region. The analysts also offer an unbiased analysis of overall market approach, target geographies and different strategies adopted by the key players across the globe to strengthen their market position in the next few years. Another section of the report consists of Crohns disease epidemiology, treatment paradigms and medications for the disease. The value chain of the market included in this report adds focus towards enhancing patient safety and product innovation that are key features expected to emerge in the global Crohns disease market.

The report concludes with a study of the market performance of some of the top companies operating in the global Crohns disease market. Persistence Market Research analysts have profiled some of the leading market players and presented a detailed analysis of their overall business performance and a comprehensive evaluation of their short-term and long-term business and go-to-market strategies. This section is intended to provide report audiences with a dashboard view of the competitive landscape of the global Crohns disease market.

Market segmentation

By Drug Type

  • Anti-inflammatory drugs
  • Immune system suppressors
  • Antibiotics
  • Biologics
  • Anti-diarrheal
  • Pain relievers

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • MEA

Exclusive research methodology

Yearly change in inflation rate has not been factored in while forecasting market numbers. While researching this report indicators such as R&D expenditure, research funding from government and non-profit organizations etc. have been considered to arrive at the indicated market numbers. A bottom-up approach has been used to evaluate market numbers for each product category, while top-down approach has been used to counter-validate the reached numbers. The analysts have done in-depth secondary research to ascertain overall market size, top industry players, and top products. In order to conduct expert and industry interviews, Persistence Market Research has formulated a detailed discussion guide, post which the analysts have conducted interviews with industry experts, industry players, retailers and distributors.

Market examination on Year-on-Year growth parameter

It is imperative to note that in an ever-fluctuating global economy, the report not only conducts forecasts in terms of CAGR but also analyzes the market on the basis of key parameters such as Year-on-Year (Y-o-Y) growth to understand the predictability of the market and to identify the right opportunities in the global Crohns disease market. Another key feature of this report is the analysis of the global Crohns disease market by region, drug type, by distribution channel and its revenue forecast in terms of absolute dollar opportunity. This is usually overlooked while forecasting the market. However, absolute dollar opportunity is critical in assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales perspective in the global Crohns disease market. In order to understand key market segments in terms of growth and performance in the global Crohns disease market, Persistence Market Research has developed a market attractiveness index to help providers identify real market opportunities.

Company Profiles

  • Allergan, Inc.,
  • UCB S.A.
  • AbbVie Inc.
  • Perrigo Company plc
  • Takeda Pharmaceutical Company Limited
  • Pfizer Inc.
  • Johnson & Johnson Services, Inc.
  • Bayer AG
  • Ferring B.V.
  • Others

Table of Content

1. Executive Summary

2. Crohns Disease Market Overview

2.1. Introduction
2.1.1. Market Definition
2.1.2. Market Taxonomy
2.2. Crohns Disease Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Value Chain
2.3. Epidemiology
2.4. Inflammatory Bowel Disease (IBD) Stepwise Treatment Paradigm
2.5. Medications for Crohns Disease- Current & Future Therapies

3. Global Crohns Disease Market Forecast, 20162024
3.1. Introduction
3.1.1. Y-o-Y Growth Projections
3.1.2. Absolute $ Opportunity
3.2. Crohns Disease Market Trends

4. Global Crohns Disease Market Analysis, By Drug Type
4.1. Introduction
4.1.1. Basis Point Share (BPS) Analysis By Drug Type
4.1.2. Y-o-Y Growth Projections By Drug Type
4.2. Market Size (US$ Mn) Forecast & Absolute $ Opportunity By Drug Type
4.2.1. Anti-inflammatory drugs
4.2.2. Immune system suppressors
4.2.3. Antibiotics
4.2.4. Biologics
4.2.5. Anti-diarrheal
4.2.6. Pain relievers
4.3. Attractiveness Analysis By Drug Type

5. Global Crohns Disease Market Analysis, By Distribution Channel
5.1. Introduction
5.1.1. Basis Point Share (BPS) Analysis By Distribution Channel
5.1.2. Y-o-Y Growth Projections By Distribution Channel
5.2. Market Size (US$ Mn) Forecast & Absolute $ Opportunity By Distribution Channel
5.2.1. Hospitals
5.2.2. Retail Pharmacies
5.2.3. Online Pharmacies
5.2.4. Drug Stores
5.3. Market Attractiveness Analysis, By Distribution Channel

6. Global Crohns Disease Market Analysis, By Region
6.1. Introduction
6.1.1. Basis Point Share (BPS) Analysis By Region
6.1.2. Y-o-Y Growth Projections By Region
6.2. Market Size (US$ Mn) Forecast & Absolute $ Opportunity By Region
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa (MEA)
6.3. Market Attractiveness Analysis By Region

7. North America Crohns Disease Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis By Country
7.1.2. Y-o-Y Growth Projections By Country
7.1.3. Market Attractiveness Analysis By Country
7.2. Market Size (US$ Mn) Forecast By Country
7.2.1. U.S.
7.2.2. Canada
7.3. Market Size (US$ Mn) Forecast By Drug type
7.3.1. Anti-inflammatory drugs
7.3.2. Immune system suppressors
7.3.3. Antibiotics
7.3.4. Biologics
7.3.5. Anti-diarrheal
7.3.6. Pain relievers
7.4. Market Size (US$ Mn) Forecast By Distribution Channel
7.4.1. Hospitals
7.4.2. Retail Pharmacies
7.4.3. Online Pharmacies
7.4.4. Drug Stores
7.5. Market Attractiveness Analysis
7.5.1. By Country
7.5.2. By Drug Type
7.5.3. By Distribution Channel

8. Latin America Crohns Disease Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis By Country
8.1.2. Y-o-Y Growth Projections By Country
8.1.3. Market Attractiveness Analysis By Country
8.2. Market Size (US$ Mn) Forecast By Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Latin America
8.3. Market Size (US$ Mn) Forecast By Drug type
8.3.1. Anti-inflammatory drugs
8.3.2. Immune system suppressors
8.3.3. Antibiotics
8.3.4. Biologics
8.3.5. Anti-diarrheal
8.3.6. Pain relievers
8.4. Market Size (US$ Mn) Forecast By Distribution Channel
8.4.1. Hospitals
8.4.2. Retail Pharmacies
8.4.3. Online Pharmacies
8.4.4. Drug Stores
8.5. Market Attractiveness Analysis
8.5.1. By Country
8.5.2. By Drug Type
8.5.3. By Distribution Channel

9. Europe Crohns Disease Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis By Country
9.1.2. Y-o-Y Growth Projections By Country
9.1.3. Market Attractiveness Analysis By Country
9.2. Market Size (US$ Mn) Forecast By Country
9.2.1. Germany
9.2.2. U.K.
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Market Size (US$ Mn) Forecast By Drug type
9.3.1. Anti-inflammatory drugs
9.3.2. Immune system suppressors
9.3.3. Antibiotics
9.3.4. Biologics
9.3.5. Anti-diarrheal
9.3.6. Pain relievers
9.4. Market Size (US$ Mn) Forecast By Distribution Channel
9.4.1. Hospitals
9.4.2. Retail Pharmacies
9.4.3. Online Pharmacies
9.4.4. Drug Stores
9.5. Market Attractiveness Analysis
9.5.1. By Country
9.5.2. By Drug Type
9.5.3. By Distribution Channel

10. Asia Pacific Crohns Disease Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis By Country
10.1.2. Y-o-Y Growth Projections By Country
10.1.3. Market Attractiveness Analysis By Country
10.2. Market Size (US$ Mn) Forecast By Country
10.2.1. China
10.2.2. Japan
10.2.3. India
10.2.4. Australia and New Zealand
10.2.5. ASEAN
10.2.6. Rest of Asia-Pacific
10.3. Market Size (US$ Mn) Forecast By Drug type
10.3.1. Anti-inflammatory drugs
10.3.2. Immune system suppressors
10.3.3. Antibiotics
10.3.4. Biologics
10.3.5. Anti-diarrheal
10.3.6. Pain relievers
10.4. Market Size (US$ Mn) Forecast By Distribution Channel
10.4.1. Hospitals
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.4.4. Drug Stores
10.5. Market Attractiveness Analysis
10.5.1. By Country
10.5.2. By Drug Type
10.5.3. By Distribution Channel

11. Middle East and Africa (MEA) Crohns Disease Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis By Country
11.1.2. Y-o-Y Growth Projections By Country
11.1.3. Market Attractiveness Analysis By Country
11.2. Market Size (US$ Mn) Forecast By Country
11.2.1. GCC Countries
11.2.2. South Africa
11.2.3. Rest of MEA
11.3. Market Size (US$ Mn) Forecast By Drug type
11.3.1. Anti-inflammatory drugs
11.3.2. Immune system suppressors
11.3.3. Antibiotics
11.3.4. Biologics
11.3.5. Anti-diarrheal
11.3.6. Pain relievers
11.4. Market Size (US$ Mn) Forecast By Distribution Channel
11.4.1. Hospitals
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.4.4. Drug Stores
11.5. Market Attractiveness Analysis
11.5.1. By Country
11.5.2. By Drug Type
11.5.3. By Distribution Channel

12. Competition Landscape
12.1. Competition Dashboard
12.2. Company Profiles (Details Overview, Financials, Strategy, Recent Developments)
12.3. Global Players
12.3.1. Allergan, Inc.,
12.3.2. UCB S.A.
12.3.3. AbbVie Inc.
12.3.4. Perrigo Company plc
12.3.5. Takeda Pharmaceutical Company Limited
12.3.6. Pfizer Inc.
12.3.7. Johnson & Johnson Services, Inc.
12.3.8. Bayer AG
12.3.9. Ferring B.V.

13. Assumptions and Acronyms Used

14. Research Methodology

List of Table

Table 01: Global Crohns Disease Market Value (US$ Mn) Analysis and Forecast By Drug Type, 20152024
Table 02: Global Crohns Disease Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 20152024
Table 03: Global Crohns Disease Market Value (US$ Mn) Analysis and Forecast By Region, 20152024
Table 04: North America Crohns Disease Market Value (US$ Mn) Analysis and Forecast By Country, 20152024
Table 05: North America Crohns Disease Market Value (US$ Mn) Analysis and Forecast By Drug Type, 20152024
Table 06: North America Crohns Disease Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 20152024
Table 07: Latin America Crohns Disease Market Value (US$ Mn) Analysis and Forecast By Country, 20152024
Table 08: Latin America Crohns Disease Market Value (US$ Mn) Analysis and Forecast By Drug Type, 20152024
Table 09: Latin America Crohns Disease Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 20152024
Table 10: Europe Crohns Disease Market Value (US$ Mn) Analysis and Forecast By Country, 20152024
Table 11: Europe Crohns Disease Market Value (US$ Mn) Analysis and Forecast By Drug Type, 20152024
Table 12: Europe Crohns Disease Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 20152024
Table 13: APAC Crohns Disease Market Value (US$ Mn) Analysis and Forecast By Country, 20152024
Table 14: APAC Crohns Disease Market Value (US$ Mn) Analysis and Forecast By Drug Type, 20152024
Table 15: APAC Crohns Disease Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 20152024
Table 16: MEA Crohns Disease Market Value (US$ Mn) Analysis and Forecast By Country, 20152024
Table 17: MEA Crohns Disease Market Value (US$ Mn) Analysis and Forecast By Drug Type, 20152024
Table 18: MEA Crohns Disease Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 20152024

List of Chart

Figure 01: Global Crohns Disease Market Value Share By, Region, 2015 A
Figure 02: Global Crohns Disease Market Value Share By, Drug Type, 2015 A
Figure 03: Global Crohns Disease Market Value Share By, Distribution Channel, 2015 A
Figure 04: Global Crohns Disease Market Value (US$ Mn) & Y-o-Y Growth (%), 20152024
Figure 05: Global Crohns Disease Market Absolute $ Opportunity, 20162024
Figure 06: Global Crohns Disease Market Share and BPS Analysis (%) By Drug Type, 2016 & 2024
Figure 07: Global Crohns Disease Y-o-Y growth (%) By Drug Type, 20162024
Figure 08: Global Crohns Disease Market Absolute $ Opportunity By Anti-inflammatory Drugs Segment,
Figure 09: Global Crohns Disease Market Absolute $ Opportunity By Immune System Suppressors Segment, 20162024
Figure 10: Global Crohns Disease Market Absolute $ Opportunity By Antibiotics Segment, 20162024
Figure 11: Global Crohns Disease Market Absolute $ Opportunity By Biologics Segment, 20162024
Figure 12: Global Crohns Disease Market Absolute $ Opportunity By Anti-diarrheal Segment, 20162024
Figure 13: Global Crohns Disease Market Absolute $ Opportunity By Pain Relievers Segment, 20162024
Figure 14: Global Crohns Disease Market Attractiveness Analysis By Drug Type, 20162024
Figure 15: Global Crohns Disease Market Share and BPS Analysis (%) By Distribution Channel, 2016 & 2024
Figure 16: Global Crohns Disease Y-o-Y growth (%) By Distribution Channel, 20162024
Figure 17: Global Crohns Disease Market Absolute $ Opportunity By Hospital Pharmacies Segment,
Figure 18: Global Crohns Disease Market Absolute $ Opportunity By Retail Pharmacies Segment, 20162024
Figure 19: Global Crohns Disease Market Absolute $ Opportunity By Online Pharmacies Segment, 20162024
Figure 20: Global Crohns Disease Market Absolute $ Opportunity By Drug Stores Segment, 20162024
Figure 21: Global Crohns Disease Market Attractiveness Analysis By Distribution Channel, 20162024
Figure 22: Global Crohns Disease Market Value (US$ Mn) and CAGR (%) By Region, 2015, 2020, and 2024
Figure 23: Global Crohns Disease Market Share and BPS Analysis (%) By Region, 2016 & 2024
Figure 24: Global Crohns Disease Y-o-Y growth (%) By Region, 20162024
Figure 25: North America Crohns Disease Market Absolute $ Opportunity, 20162024
Figure 26: Latin America Crohns Disease Market Absolute $ Opportunity, 20162024
Figure 27: Europe Crohns Disease Market Absolute $ Opportunity, 20162024
Figure 28: APAC Crohns Disease Market Absolute $ Opportunity, 20162024
Figure 29: Middle East and Africa Crohns Disease Market Absolute $ Opportunity, 20162024
Figure 30: Global Crohns Disease Market Attractiveness Analysis By Region, 20162024
Figure 31: North America Crohns Disease Market Share Analysis (%) By Country, 2016 & 2024
Figure 32: North America Crohns Disease Market Attractiveness Analysis By Country, 20162024
Figure 33: North America Crohns Disease Y-o-Y growth (%) By Country, 20162024
Figure 34: North America Crohns Disease Market Attractiveness Analysis By Drug Type, 20162024
Figure 35: North America Crohns Disease Market Attractiveness Analysis By Distribution Channel, 20162024
Figure 36: Latin America Crohns Disease Market Share Analysis (%) By Country, 2016 & 2024
Figure 37: Latin America Crohns Disease Market Attractiveness Analysis By Country, 20162024
Figure 38: Latin America Crohns Disease Y-o-Y growth (%) By Country, 20162024
Figure 39: Latin America Crohns Disease Market Attractiveness Analysis By Drug Type, 20162024
Figure 40: Latin America Crohns Disease Market Attractiveness Analysis By Distribution Channel, 20162024
Figure 41: Europe Crohns Disease Market Share Analysis (%) By Country, 2016 & 2024
Figure 42: Europe Crohns Disease Market Attractiveness Analysis By Country, 20162024
Figure 43: Europe Crohns Disease Y-o-Y growth (%) By Country, 20162024
Figure 44: Europe Crohns Disease Market Attractiveness Analysis By Drug Type, 20162024
Figure 45: Europe Crohns Disease Market Attractiveness Analysis By Distribution Channel, 20162024
Figure 46: APAC Crohns Disease Market Share Analysis (%) By Country, 2016 & 2024
Figure 47: APAC Crohns Disease Market Attractiveness Analysis By Country, 20162024
Figure 48: APAC Crohns Disease Y-o-Y growth (%) By Country, 20162024
Figure 49: APAC Crohns Disease Market Attractiveness Analysis By Drug Type, 20162024
Figure 50: APAC Crohns Disease Market Attractiveness Analysis By Distribution Channel, 20162024
Figure 51: MEA Crohns Disease Market Share Analysis (%) By Country, 2016 & 2024
Figure 52: MEA Crohns Disease Market Attractiveness Analysis By Country, 20162024
Figure 53: MEA Crohns Disease Y-o-Y growth (%) By Country, 20162024
Figure 54: MEA Crohns Disease Market Attractiveness Analysis By Drug Type, 20162024
Figure 55: MEA Crohns Disease Market Attractiveness Analysis By Distribution Channel, 20162024

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *